SN Bioscience’s nano-cancer therapy wins orphan drug designation
The FDA grants SN Bioscience’s nano-therapy SNB-101 an orphan drug designation for small cell lung cancer.
The FDA grants SN Bioscience’s nano-therapy SNB-101 an orphan drug designation for small cell lung cancer.
What's Your Reaction?
